Neck Carcinoma — Trials

Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 464
Recruiting: 240
Ph III recruiting: 63
Growth YoY: +3.1%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (128)

clinicaltrialsPublishedShowing 301–313 of 313 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05352321	Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma	recruiting	N/A	264	Sun Yat-sen UniversityOTHER	1	Jul 1, 2022	clinicaltrials
NCT04437329	Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma	recruiting	Phase 3	352	Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER	1	May 10, 2022